Fundraising Fox
Medexus Pharmaceuticals
Toronto, CA · 109 employees on LinkedIn · 1 known investors
Find your way into Medexus Pharmaceuticals
Sign up to see every warm intro you have to Medexus Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medexus Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Medexus Pharmaceuticals is a specialty pharmaceutical company focused on orphan drugs and rare disease treatments, with a portfolio of specialty and rare disease products. It operates a fully integrated North American business model spanning commercial operations, supply chain, regulatory, medical affairs, and sales.
Founders & leadership
Board
PV
SN
Stephen NelsonBoard director
AG
Adele GulfoBoard director
MM
Michael MuellerBoard director
BG
Benoit GravelBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$400K disclosed across 1 round · 2020
▶$400KraisedMar 2020 · 1 investors · PharmaceuticalsRule 506(b)
▶$400KraisedMar 2020 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephen NelsonDirector
- Adele GulfoDirector
- Ken d'EntremontExecutive Officer, Director
- Roland BoivinExecutive Officer
- Terri ShoemakerExecutive Officer
- Peter van der VeldenDirector
- Michael MuellerDirector
- Benoit GravelDirector
- Offering amount
- $400K
- Amount sold
- $400K
- First sale
- Feb 2020
- Incorporated
- Corporation, Canada (federal Level)
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Medicus PharmaMedicus Pharma is a biotech company that identifies, acquires, and advances clinical-stage therapeutic assets through development and commercialization. The company focuses on addressing unmet medical needs across diverse therapeutic areas.
WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
BiPar SciencesBiopharmaceutical developer of tumor-selective PARP inhibitor cancer therapies, acquired by Sanofi-aventis in 2009.
Companies working in the same space as Medexus Pharmaceuticals.
Frequently asked questions
- What does Medexus Pharmaceuticals do?
- Medexus Pharmaceuticals is a specialty pharmaceutical company focused on orphan drugs and rare disease treatments, with a portfolio of specialty and rare disease products. It operates a fully integrated North American business model spanning commercial operations, supply chain, regulatory, medical affairs, and sales.
- Who are Medexus Pharmaceuticals's investors?
- Medexus Pharmaceuticals's investors include Lumira Ventures.
- How much funding has Medexus Pharmaceuticals raised?
- Medexus Pharmaceuticals has disclosed $400K raised across 1 round.
- Where is Medexus Pharmaceuticals headquartered?
- Medexus Pharmaceuticals is headquartered in Toronto, CA.